GENRX RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

rizatriptan benzoate

forme pharmaceutique:

Tablet, orally disintegrating

Composition:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; mannitol; crospovidone; sucralose; Flavour

Mode d'administration:

Oral

Unités en paquet:

2

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

Descriptif du produit:

Visual Identification: White to off-white coloured, round-shaped tablets with "APO" engraved on one side and "RZ" over "5" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Licence status A

Date de l'autorisation:

2016-02-09